ELIA GROUP SA/NV (ELI.BR) Fundamental Analysis & Valuation

EBR:ELI • BE0003822393

Current stock price

138.7 EUR
-1.2 (-0.86%)
Last:

This ELI.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ELI.BR Profitability Analysis

1.1 Basic Checks

  • ELI had positive earnings in the past year.
  • ELI had a positive operating cash flow in the past year.
  • ELI had positive earnings in each of the past 5 years.
  • Of the past 5 years ELI 4 years had a positive operating cash flow.
ELI.BR Yearly Net Income VS EBIT VS OCF VS FCFELI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • The Return On Assets of ELI (1.73%) is worse than 88.89% of its industry peers.
  • The Return On Equity of ELI (6.83%) is worse than 85.19% of its industry peers.
  • The Return On Invested Capital of ELI (2.81%) is worse than 85.19% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ELI is below the industry average of 6.09%.
Industry RankSector Rank
ROA 1.73%
ROE 6.83%
ROIC 2.81%
ROA(3y)1.7%
ROA(5y)1.66%
ROE(3y)6.93%
ROE(5y)6.66%
ROIC(3y)3.12%
ROIC(5y)3.03%
ELI.BR Yearly ROA, ROE, ROICELI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • With a decent Profit Margin value of 12.53%, ELI is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ELI has grown nicely.
  • Looking at the Operating Margin, with a value of 23.30%, ELI is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
  • ELI's Operating Margin has been stable in the last couple of years.
  • ELI's Gross Margin of 65.27% is fine compared to the rest of the industry. ELI outperforms 62.96% of its industry peers.
  • In the last couple of years the Gross Margin of ELI has grown nicely.
Industry RankSector Rank
OM 23.3%
PM (TTM) 12.53%
GM 65.27%
OM growth 3Y17.22%
OM growth 5Y-0.29%
PM growth 3Y9.86%
PM growth 5Y2.05%
GM growth 3Y29.03%
GM growth 5Y4.73%
ELI.BR Yearly Profit, Operating, Gross MarginsELI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ELI.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELI is destroying value.
  • ELI has more shares outstanding than it did 1 year ago.
  • ELI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ELI has been reduced compared to a year ago.
ELI.BR Yearly Shares OutstandingELI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ELI.BR Yearly Total Debt VS Total AssetsELI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.79, we must say that ELI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ELI (0.79) is worse than 81.48% of its industry peers.
  • ELI has a Debt/Equity ratio of 2.07. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ELI (2.07) is worse than 85.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.41
WACC6.77%
ELI.BR Yearly LT Debt VS Equity VS FCFELI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

  • ELI has a Current Ratio of 1.22. This is a normal value and indicates that ELI is financially healthy and should not expect problems in meeting its short term obligations.
  • ELI has a better Current ratio (1.22) than 77.78% of its industry peers.
  • A Quick Ratio of 1.14 indicates that ELI should not have too much problems paying its short term obligations.
  • ELI has a better Quick ratio (1.14) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.14
ELI.BR Yearly Current Assets VS Current LiabilitesELI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ELI.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.60% over the past year.
  • The Earnings Per Share has been growing by 8.71% on average over the past years. This is quite good.
  • Looking at the last year, ELI shows a quite strong growth in Revenue. The Revenue has grown by 17.92% in the last year.
  • Measured over the past years, ELI shows a quite strong growth in Revenue. The Revenue has been growing by 14.99% on average per year.
EPS 1Y (TTM)5.6%
EPS 3Y6.56%
EPS 5Y8.71%
EPS Q2Q%-9.07%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y7.1%
Revenue growth 5Y14.99%
Sales Q2Q%-0.39%

3.2 Future

  • Based on estimates for the next years, ELI will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.13% on average per year.
  • The Revenue is expected to grow by 10.71% on average over the next years. This is quite good.
EPS Next Y21.02%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
EPS Next 5Y17.13%
Revenue Next Year14.88%
Revenue Next 2Y17.2%
Revenue Next 3Y15.93%
Revenue Next 5Y10.71%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ELI.BR Yearly Revenue VS EstimatesELI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ELI.BR Yearly EPS VS EstimatesELI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. ELI.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • ELI is valuated rather expensively with a Price/Earnings ratio of 24.95.
  • 77.78% of the companies in the same industry are cheaper than ELI, based on the Price/Earnings ratio.
  • ELI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 21.90, ELI is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, ELI is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
  • ELI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 24.95
Fwd PE 21.9
ELI.BR Price Earnings VS Forward Price EarningsELI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ELI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ELI is more expensive than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.17
ELI.BR Per share dataELI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • ELI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ELI's earnings are expected to grow with 15.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.19
PEG (5Y)2.87
EPS Next 2Y16.32%
EPS Next 3Y15.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. ELI.BR Dividend Analysis

5.1 Amount

  • ELI has a Yearly Dividend Yield of 1.03%.
  • Compared to an average industry Dividend Yield of 2.97, ELI's dividend is way lower than its industry peers. On top of this 85.19% of the companies listed in the same industry pay a better dividend than ELI!
  • With a Dividend Yield of 1.03, ELI pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

  • The dividend of ELI decreases each year by -3.82%.
Dividend Growth(5Y)-3.82%
Div Incr Years6
Div Non Decr Years6
ELI.BR Yearly Dividends per shareELI.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 23.21% of the earnings are spent on dividend by ELI. This is a low number and sustainable payout ratio.
DP23.21%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
ELI.BR Yearly Income VS Free CF VS DividendELI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
ELI.BR Dividend Payout.ELI.BR Dividend Payout, showing the Payout Ratio.ELI.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ELI.BR Fundamentals: All Metrics, Ratios and Statistics

ELIA GROUP SA/NV

EBR:ELI (4/10/2026, 7:00:00 PM)

138.7

-1.2 (-0.86%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)03-05
Earnings (Next)05-20
Inst Owners27.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap15.13B
Revenue(TTM)4.44B
Net Income(TTM)556.60M
Analysts83.16
Price Target146.23 (5.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend1.38
Dividend Growth(5Y)-3.82%
DP23.21%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.95%
PT rev (3m)21.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.89%
EPS NY rev (3m)6.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.67%
Revenue NY rev (3m)-4.61%
Valuation
Industry RankSector Rank
PE 24.95
Fwd PE 21.9
P/S 3.41
P/FCF N/A
P/OCF 7.24
P/B 1.86
P/tB 3.04
EV/EBITDA 16.17
EPS(TTM)5.56
EY4.01%
EPS(NY)6.33
Fwd EY4.57%
FCF(TTM)-27.05
FCFYN/A
OCF(TTM)19.17
OCFY13.82%
SpS40.73
BVpS74.72
TBVpS45.66
PEG (NY)1.19
PEG (5Y)2.87
Graham Number96.69
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 6.83%
ROCE 3.79%
ROIC 2.81%
ROICexc 3.31%
ROICexgc 3.84%
OM 23.3%
PM (TTM) 12.53%
GM 65.27%
FCFM N/A
ROA(3y)1.7%
ROA(5y)1.66%
ROE(3y)6.93%
ROE(5y)6.66%
ROIC(3y)3.12%
ROIC(5y)3.03%
ROICexc(3y)3.52%
ROICexc(5y)3.72%
ROICexgc(3y)4.2%
ROICexgc(5y)4.69%
ROCE(3y)4.22%
ROCE(5y)4.09%
ROICexgc growth 3Y-10.14%
ROICexgc growth 5Y-1.74%
ROICexc growth 3Y-5.25%
ROICexc growth 5Y0.12%
OM growth 3Y17.22%
OM growth 5Y-0.29%
PM growth 3Y9.86%
PM growth 5Y2.05%
GM growth 3Y29.03%
GM growth 5Y4.73%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Debt/EBITDA 9.52
Cap/Depr 679.71%
Cap/Sales 113.47%
Interest Coverage 2.41
Cash Conversion 117.67%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.14
Altman-Z 0.79
F-Score7
WACC6.77%
ROIC/WACC0.41
Cap/Depr(3y)616.86%
Cap/Depr(5y)483.49%
Cap/Sales(3y)99.27%
Cap/Sales(5y)77.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.6%
EPS 3Y6.56%
EPS 5Y8.71%
EPS Q2Q%-9.07%
EPS Next Y21.02%
EPS Next 2Y16.32%
EPS Next 3Y15.53%
EPS Next 5Y17.13%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y7.1%
Revenue growth 5Y14.99%
Sales Q2Q%-0.39%
Revenue Next Year14.88%
Revenue Next 2Y17.2%
Revenue Next 3Y15.93%
Revenue Next 5Y10.71%
EBIT growth 1Y17.96%
EBIT growth 3Y25.54%
EBIT growth 5Y14.66%
EBIT Next Year105.64%
EBIT Next 3Y44.55%
EBIT Next 5Y31.89%
FCF growth 1Y20.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y121.39%
OCF growth 3Y13.46%
OCF growth 5YN/A

ELIA GROUP SA/NV / ELI.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELIA GROUP SA/NV?

ChartMill assigns a fundamental rating of 4 / 10 to ELI.BR.


What is the valuation status of ELIA GROUP SA/NV (ELI.BR) stock?

ChartMill assigns a valuation rating of 1 / 10 to ELIA GROUP SA/NV (ELI.BR). This can be considered as Overvalued.


Can you provide the profitability details for ELIA GROUP SA/NV?

ELIA GROUP SA/NV (ELI.BR) has a profitability rating of 5 / 10.


What is the financial health of ELIA GROUP SA/NV (ELI.BR) stock?

The financial health rating of ELIA GROUP SA/NV (ELI.BR) is 2 / 10.


What is the expected EPS growth for ELIA GROUP SA/NV (ELI.BR) stock?

The Earnings per Share (EPS) of ELIA GROUP SA/NV (ELI.BR) is expected to grow by 21.02% in the next year.